Endothelin A Receptor Antagonist, Atrasentan, Attenuates Renal and Cardiac Dysfunction in Dahl Salt-Hypertensive Rats in a Blood Pressure Independent Manner
Ligand search results | IUPHAR/BPS Guide to PHARMACOLOGY
Pathophysiological role of endothelin in chronic kidney disease (CKD)... | Download Scientific Diagram
Atrasentan - Wikipedia
Atrasentan (ABT-627) | Endothelin Receptor Antagonist | MedChemExpress
Chinook Therapeutics Obtains Worldwide Rights from AbbVie to Atrasentan with Plans to Develop for the Treatment of Kidney Diseases | Business Wire
Atrasentan Mechanism of Action - YouTube
JCM | Free Full-Text | Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy | HTML
Endothelin-targeted new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibition | SpringerLink
Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease | Hypertension
Endothelin Receptors and Their Antagonists - ScienceDirect
Atrasentan-based Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: Atrasentan, an endothelin receptor antagonist selective for subtype A (ETA) used to treat cancer, pulmonary hypertension, diabetic kidney diseases and ...
Endothelins in cardiovascular biology and therapeutics | Nature Reviews Cardiology
IJMS | Free Full-Text | Glucose and Blood Pressure-Dependent Pathways–The Progression of Diabetic Kidney Disease | HTML
Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy. - Abstract - Europe PMC
Endocrine aspects of bone metastases - The Lancet Diabetes & Endocrinology
Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy | Scientific Reports
Atrasentan hydrochloride | C29H39ClN2O6 - PubChem
Atrasentan - an overview | ScienceDirect Topics
SONAR propels endothelin A receptor antagonists to success | Nature Reviews Nephrology
Atrasentan | Chinook Therapeutics
Atrasentan treatment modulates of fi ce and 24-hour ambulatory blood... | Download Scientific Diagram
Atrasentan for the treatment of diabetic nephropathy: Expert Opinion on Investigational Drugs: Vol 26, No 6
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy - Heerspink - 2018 - Diabetes, Obesity and Metabolism - Wiley Online Library
Atrasentan | Chinook Therapeutics
Atrasentan treatment signi fi cantly decreases albuminuria. (A) UACR... | Download Scientific Diagram
